Dashboard
Manage Tickers

BMYBRISTOL MYERS SQUIBB CO

NYSE bms.com


$ 41.13 $ 0.84 (2.09 %)    

Friday, 31-May-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 41.09
$ 40.17
$ 0.00 x 0
$ 0.00 x 0
$ 40.15 - $ 41.15
$ 39.91 - $ 63.72
28,450,109
na
83.29B
$ 0.53
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-13-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-25-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-13-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 10-24-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fda-expands-approval-for-bristol-myers-squibbs-breyanzi-making-car-t-cell-therapy-available-for-broadest-range-of-b-cell-malignancies
FDA Expands Approval For Bristol Myers Squ...
05/31/2024 18:14:15

FDA approves Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) for relapsed or refractory mantle cell lymphoma, ma...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/31/2024 17:35:21

bristol-myers-squibbs-options-a-look-at-what-the-big-money-is-thinking
Bristol-Myers Squibb's Options: A Look at ...
05/30/2024 17:15:42

bristol-myers-squibb-announces-fda-approval-of-breyanzi-for-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma
Bristol Myers Squibb Announces FDA Approva...
05/30/2024 15:52:16

are-boomers-crashing-the-economy-or-saving-it-why-investors-are-perplexed-and-what-you-can-do-to-prepare
Are Boomers Crashing The Economy Or Saving...
05/29/2024 14:51:04

Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest w...

european-commission-approves-bristol-myers-squibbs-opdivo-nivolumab-in-combination-with-cisplatin-and-gemcitabine-for-the-first-line-treatment-of-unresectable-or-metastatic-urothelial-carcinoma
European Commission Approves Bristol Myers...
05/29/2024 11:11:15

Approval based on results from CheckMate -901, the first Phase 3 trial in this patient population with an immunotherapy-chemo...

Core News & Articles
Prothena to Receive $80 Million from Brist...
05/28/2024 20:08:17

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/28/2024 17:35:22

wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields
Wall Street's Most Accurate Analysts Say H...
05/28/2024 12:56:32

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/24/2024 17:35:24

whats-going-on-with-mid-cap-cancer-focused-verastem-oncology-stock-on-friday
What's Going On With Mid-Cap Cancer-Focuse...
05/24/2024 12:45:21

Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in ...

bristol-myers-squibb-to-present-data-across-its-oncology-and-hematology-portfolio-at-upcoming-asco-annual-meeting-and-eha-hybrid-congress
Bristol Myers Squibb To Present Data Acros...
05/23/2024 21:52:53

bmy---analyzing-bristol-myers-squibbs-short-interest
(BMY) - Analyzing Bristol-Myers Squibb's S...
05/23/2024 17:45:15

bristol-myers-squibb-to-present-karxt-data-at-ascp-may-28-31
Bristol Myers Squibb To Present KarXT Data...
05/23/2024 11:01:35

hawaii-court-rules-against-bristol-myers-sanofi-in-blood-clot-drug-case-increases-liability-to-916m
Hawaii Court Rules Against Bristol Myers, ...
05/22/2024 17:25:12

A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the hea...

bristol-myers-squibb-announced-aspire-a-10-year-strategy-with-an-aim-to-reach-over-200000-patients-in-low-and-middle-income-countries-by-2033-as-part-of-aspire-bristol-myers-is-developing-tailored-strategies-to-increase-affordability-and-availability
Bristol Myers Squibb Announced Aspire, A 1...
05/22/2024 11:08:56

spotlight-on-bristol-myers-squibb-analyzing-the-surge-in-options-activity
Spotlight on Bristol-Myers Squibb: Analyzi...
05/21/2024 15:45:56

the-fda-has-reassigned-prescription-drug-user-fee-act-date-for-bristol-myers-squibbs-subcutaneous-formulation-of-opdivo-nivolumab-across-all-previously-approved-adult-solid-tumor-opdivo-indications-the-updated-goal-date-is-december-29
The FDA Has Reassigned Prescription Drug U...
05/21/2024 11:01:55

abbvie-is-successfully-positioned-to-absorb-humira-biosimilar-erosion--analyst
AbbVie Is 'Successfully Positioned To Abso...
05/17/2024 17:47:16

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humir...

Core News & Articles
On CNBC, Jason Snipe Announced Bought More...
05/17/2024 17:01:43

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION